- Scrip Originals
- Featured Topics
Brought to you by
Avalon Pharmaceuticals closes $70mm Series B financing
13 Oct 2011
Avalon Pharmaceuticals (small-molecule cancer drugs) completed its Series B financing round, raising $70mm. Array Capital LLC acted as the placement agent.
Drug Discovery Tools
- Drug Discovery Tools
- Venture Financing
Already a Biomedtracker subscriber? You have access to the full deal record through your subscription
Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com